Cerebral infarction

About cerebral infarction

A cerebral infarction is an area of necrotic (dead) brain tissue. It is caused by an interruption in blood and oxygen supply to the brain due to a blockage or narrowing of the arteries. Symptoms can vary depending on the area of the brain affected. Factors increasing the risk of cerebral infarction include high blood pressure, diabetes mellitus, tobacco smoking, obesity, and dyslipidemia1.


References

1. Cerebral infarction.
Wikipedia. Cited on 13/03/2018.
  1. Radicut (edaravone) — FDA approved under the brand name Radicava
    Radicut (edaravone) — FDA approved under the brand name Radicava
    by Mitsubishi Tanabe Pharma Co., Ltd.
    for Amyotrophic Lateral Sclerosis (ALS), Cerebral Infarction
    €992.00
  2. Edaravone (generic)
    Edaravone (generic)
    by Daiichi Sankyo Company Limited
    for Cerebral Infarction
    €545.00
View as Grid List

2 Items

per page
Set Descending Direction

One more step before you can continue

Our service contains information about acquiring medicines that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

Scroll down.

No, I'd like to receive general information only.

Disclaimer: The information TSM provides is aimed at patients with terminal and life-debilitating diseases, their doctors and healthcare professionals. It supports an informed decision by the treating doctor about the patient’s treatment and the consideration of a medicine which has not been approved in the patient’s country.